Clinical trial

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer

NCT03995667

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-06-11

PhasePHASE2

Study timeline

Study start (actual)2019-06-11Date precision: day

Registry last updated2023-10-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Extensive Stage Lung Small Cell Carcinomaunresolved

Limited Stage Lung Small Cell Carcinomaunresolved

Stage I Lung Cancer AJCC v8unresolved

Stage IA1 Lung Cancer AJCC v8unresolved

Stage IA2 Lung Cancer AJCC v8unresolved

Stage IA3 Lung Cancer AJCC v8unresolved

Stage IB Lung Cancer AJCC v8unresolved

Stage II Lung Cancer AJCC v8unresolved

Stage IIA Lung Cancer AJCC v8unresolved

Stage IIB Lung Cancer AJCC v8unresolved

Stage III Lung Cancer AJCC v8unresolved

Stage IIIA Lung Cancer AJCC v8unresolved

Stage IIIB Lung Cancer AJCC v8unresolved

Stage IIIC Lung Cancer AJCC v8unresolved

Stage IV Lung Cancer AJCC v8unresolved

Stage IVA Lung Cancer AJCC v8unresolved

Stage IVB Lung Cancer AJCC v8unresolved

Interventions

Questionnaire AdministrationOTHER

Tumor Treating Fields TherapyDEVICE

Sponsors & collaborators

OHSU Knight Cancer Institutelead sponsor

NovoCure Ltd.collaborator

Oregon Health and Science Universitycollaborator

Mapped research locations

PortlandOregon, United States1 PhoenixArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03995667 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.